We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cispharma Gets Form 483 Over Testing, Drug Quality Concerns
Cispharma Gets Form 483 Over Testing, Drug Quality Concerns
October 1, 2012
Cispharma has received a Form 483 with several manufacturing observations, including a lack of evidence that a distributed portion of a lot was acceptable.